Form 4 Tracker
Niagen Bioscience, Inc.
NAGE

14 insider filings · Latest: Jun 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Dec 13, 2024Dec 13 6:54 PMFrank Jaksch Jr.
Proposed Sale
37,161$6.19$230.0K

View →

Aug 23, 2024Aug 23 3:52 PMKristin Patrick
Proposed Sale
23,000$3.69$84.8K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 24, 2026Jun 26 10:03 PMWing Tak Wendy YUDirector
Grant/Award
31,746$3.4531,746(D)

View →

Jun 24, 2026Jun 26 10:02 PMWang Yu Gary NgDirector
Grant/Award
31,746$3.4531,746(D)

View →

Jun 24, 2026Jun 26 10:01 PMAnn CohenDirector
Grant/Award
31,746$3.4531,746(D)

View →

Jun 24, 2026Jun 26 9:57 PMKristin PatrickDirector
Grant/Award
31,746$3.4531,746(D)

View →

Jun 24, 2026Jun 26 9:56 PMHamed ShahbaziDirector
Grant/Award
31,746$3.4531,746(D)

View →

Jun 24, 2026Jun 26 9:55 PMSteven D RubinDirector
Grant/Award
31,746$3.4531,746(D)

View →

Jun 24, 2026Jun 26 9:54 PMFrank L Jaksch JrDirector
Grant/Award
31,746$3.4531,746(D)

View →

Apr 24, 2026Apr 27 12:33 PMFried Robert NDirector, Chief Executive Officer
Option Exercise
20,000$2.610(D)

View →

Feb 19, 2026Feb 24 9:47 PMCarlos Luis LopezSVP, General Counsel
Grant/Award
41,420$4.9441,420(D)

View →

Feb 19, 2026Feb 24 9:46 PMOzan PamirChief Financial Officer
Grant/Award
62,131$4.9462,131(D)

View →

Feb 19, 2026Feb 24 9:44 PMFried Robert NDirector, Chief Executive Officer
Grant/Award
503,937$4.94503,937(D)

View →